About Us

Our Conference

The Boston Investment Conference gathers the brightest minds in the investment community together for a full day of insights, ideas and networking. Each year, conference proceeds benefit a new research initiative at Boston Children’s Hospital, as well as unique collaborations between Boston Children’s and the Broad Institute.


Our Impact

Boston Children’s Hospital is at the leading edge of combined gene therapy and stem cell treatments that not only promise to cure children with devastating illnesses, but could pave the way to revolutionizing how we treat all degenerative brain disorders. This year, the Boston Investment Conference will support the work of Alessandra Biffi, MD, the director of our gene therapy program and a world-renowned expert in the treatment of rare neurological diseases.

With BIC support, Dr. Biffi will launch a first-in-human clinical trial of a novel therapy that places stem cells directly into the brain—in addition to the blood—resulting in faster and more robust production of genetically corrected cells. She will use this therapy to treat children who suffer from a debilitating and until now fatal genetic illness. In addition to saving lives, the trial will advance our understanding of how this revolutionary approach can be used to cure common neurological disorders that affect millions—both children and adults—worldwide.


Boston Children's Hospital

Boston Children’s Hospital has been quietly changing the future of health for every child, here and around the world, since 1869. Named the number one hospital for care in the country, we are also the largest research center for pediatric medicine anywhere.

We have a legacy of medical breakthroughs; many leading to treatments for adults. Discoveries include the first measles vaccine, the first remission of leukemia, and the first solid organ transplant. We have been home to two Nobel Laureates, eight Lasker Award (America’s Nobel) winners, and four MacArthur “Genius Grant” Fellows. Boston Children’s receives more NIH grants than any other pediatric institution.


Speakers

Thank you to our 2018 speakers.
For a full list of our previous speakers, click here.

Lloyd Blankfein

Goldman Sachs

Bihua Chen

Cormorant Asset Management, LP

Joel Cutler

General Catalyst

Fred Ehrsam

Paradigm

Ronald D. Fisher

SoftBank Group

James E. Flynn

James E. Flynn

Deerfield

Matt Huang

Paradigm

Munib Islam

Third Point

Seth Klarman

The Baupost Group, LLC

Adam M. Koppel

Bain Capital Life Sciences

Jonathan S. Lavine

Bain Capital

Keith Meister

Corvex Management LP

Narv Narvekar

Harvard Management Company

Ted Pappendick

Bain Capital

Benjamin Pass

TOMS Capital Investment Management

André Perold

High Vista Strategies

David M. Rubenstein

The Carlyle Group

Ricky Sandler

Eminence Capital, LP

Our 2018 Sponsors

Capital Gains Sponsor

Bull Market Sponsor

Dividend Sponsor

Capital Gains Sponsor

Dividend Sponsor

Dividend Sponsor

Capital Gains Sponsor

Dividend Sponsor

Capital Gains Sponsor

Capital Gains Sponsor

Dividend Sponsor

Capital Gains Sponsor

Dividend Sponsor

IPO Sponsor

Dividend Sponsor

Dividend Sponsor

Bull Market Sponsor

Bull Market Sponsor

Dividend Sponsor  

Capital Gains Sponsor

IPO Sponsor

IPO Sponsor

Bull Market Sponsor

IPO Sponsor

IPO Sponsor

Dividend Sponsor

IPO Sponsor

Dividend Sponsor

Dividend Sponsor

Capital Gains Sponsor

Dividend Sponsor

IPO Sponsor

Bull Market Sponsor

Capital Gains Sponsor

Dividend Sponsor